Panbela Therapeutics Inc   (PBLA)
Other Ticker:  

Panbela Therapeutics Inc 's Working Capital Per Sales

PBLA's Working Capital and Revenue growth

PBLA Working Capital Per Revenue (Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Working Capital Change - - - - -
Y / Y Revenue Change - - - - -
Working Capital Per Revenue - - - - -
Total Ranking # # # # #
Seq. Working Capital Change - - - - -
Seq. Revenue Change - - - - -

Comment on PBLA's Working Capital Per Revenue in the second quarter 2023

Within Healthcare sector Panbela Therapeutics Inc has achieved the lowest Working Capital Per Revenue. While Working Capital Per Revenue remained unchanged in the Q2 2023 relative to the prior quarter at no. .
Working Capital Per Revenue Ranking
Within: No.
Industry #
Sector #
S&P 500 #

Working Capital Per Revenue Statistics
High Average Low

Financial Statements
Panbela Therapeutics Inc 's Working Capital $ 0 Millions Visit PBLA's Balance sheet
Panbela Therapeutics Inc 's Revenues $ 0 Millions Visit PBLA's Income Statement
Where are PBLA's Sales coming from? Visit PBLA's Sales by Geography

Companies with similar Average Working Capital Per Revenue for 12 months ending Jun 30 2023, within Healthcare Sector Working Capital Per Revenue
Date modified: 2023-08-11T16:51:33+00:00


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com